MSC-2 (Sanbio)

N/A

Report date: 2023/12/14 13:36:03

Base Information

Drug NameMSC-2 (Sanbio)
Drug Alias NameOT-1602
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionImmunosuppressantsCell replacements
TargetsNot applicable
Therapy Area/IndicationsInflammationDiabetic RetinopathyOptic Neuritis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHong KongJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesD&P Bioinnovations IncSanbioSanBio Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsInflammationDiabetic RetinopathyOptic Neuritis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A